Clinical Presentations

In this week’s Homerun Slides, Incretins, Part 5 of 6, we review the tissue-specific differences in the mechanisms of action of GLP-1 analogs, DPP-4 inhibitors, and GLP-1R agonists and also discuss the weight effects of sitagliptin and pioglitazone….

In this Special Edition on DPP-IV Inhibitors, we present a set of our Homerun Slides focused on The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes….

In this week’s Homerun Slides, we cover DPP-IV inhibitors including a comparison of effects with GLP-1 receptor agonists….

This week we continue our six part series on Incretins with Homerun Slides focused on Sitagliptin….

This week with Part 2 of our new Incretins series of Homerun Slides, we cover "Incretin Physiology in Type 2 Diabetes Mellitus" and "GLP-1 & GIP Secretion in Type 2 Diabetes Mellitus"….

This first of seven sets of Homerun Slides begins with GLP-1 physiology, then examines the actions of DPP-4 inhiitors and GLP-1R agonists, plus….

This week we conclude our five-part series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents. This week’s slides include coverage of Liraglutide and Pramlintide….

This week we continue with Part 4 of our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents. Slides this week cover Exenatide, a synthetic version of Exendin-4 which is found in the saliva of the Gila monster….

We continue this week with our Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents with slides on Incretins and DPP 4 Inhibitors….

  This week we continue our series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents with information on Colesevelam….